The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues.
Open accessAbstract
The neurofibromatosis (NF1) gene shows significant homology to mammalian GAP and is an important regulator of the ras signal transduction pathway. To study the function of NF1 in normal development and to try and develop a mouse model of NF1 disease, we have used gene targeting in ES cells to generate mice carrying a null mutation at the mouse Nf1 locus. Although heterozygous mutant mice, aged up to 10 months, likely attributable to a severe malformation of the heart. Interestingly, mutant embryos also display hyperplasia of neural crest-derived sympathetic ganglia. These results identify new roles for NF1 in development and indicate that some of the abnormal growth phenomena observed in NF1 patients can be recapitulated in neurofibromin-deficient mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Consistent with this, Nf1 deficiency induces a myeloproliferative disorder in murine models (8,9).”
From PU.1, Interferon Regulatory Factor (IRF) 2, and the Interferon Consensus Sequence-binding Protein (ICSBP/IRF8) Cooperate to Activate NF1 Transcription in Differentiating Myeloid Cells (2007) · cites this paper as [8]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
(1968) · Medical Entomology and Zoology · Cited by 4,924
Manipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells
Thomas, K. R., & Capecchi, M. R. (1987) · Cell · doi:10.1016/0092-8674(87)90646-5 · Cited by 2,355
Simplified mammalian DNA isolation procedure
Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., & Berns, A. J. M. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4293 · Cited by 1,497
Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients
Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H. M., Saulino, A. M., Fountain, J. W., Brereton, A., Nicholson, J. M., Mitchell, A. L., et al. (1990) · Science · doi:10.1126/science.2134734 · Cited by 1,478
Von Recklinghausen Neurofibromatosis
Riccardi, V. M. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112313052704 · Cited by 1,353
Neural Crest Cells Contribute to Normal Aorticopulmonary Septation
Kirby, M. L., Gale, T. F., & Stewart, D. E. (1983) · Science · doi:10.1126/science.6844926 · Cited by 1,118
The neurofibromatosis type 1 gene encodes a protein related to GAP
Xu, G., O'Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90024-9 · Cited by 1,095
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
Viskochil, D. H., Buchberg, A. M., Xu, G., Cawthon, R., Stevens, J., Wolff, R. K., Culver, M., Carey, J. C., Copeland, N. G., Jenkins, N. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90252-a · Cited by 1,082
Self-citation
Research works printed but not linked: 2
- 1986, Neurofibromatosis and cancer., Ann. N.Y. Acad. Sci., 486, 56
- 1972, Birth defects: Original article series, 8, 92
Cited by
Sorted by citations
Items 501–600 of 640
A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/– mice
Park, S. J., Lukkes, J. L., Chan, K.-K., Drozd, H. P., Burgin, C. B., Qian, S., Sullivan, M. M., Guevara, C. G., Cunningham, N., Arenas, S., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188932 · Cited by 4
Marquez, R. B., Sánchez-Vásquez, E., Alonso, A. M., Bernardi, Y. E., Santillán, E. M., Lwigale, P. Y., Cochella, L., Bronner-Fraser, M. E., & Strobl‐Mazzulla, P. H. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2517668122 · Cited by 3
Control of Retinal Development by Tumor Suppressor Genes
Cantrup, R., Kaushik, G., & Schuurmans, C. (2012) · InTech eBooks · doi:10.5772/28870 · Cited by 5
Sango, K., Tsukamoto, M., Utsunomiya, K., & Watabe, K. (2014) · Springer eBooks · doi:10.1007/978-4-431-54764-8_10 · Cited by 3
NF1-Dependent Transcriptome Regulation in the Melanocyte Lineage and in Melanoma
Larribère, L., & Utikal, J. S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153350 · Cited by 3
Neurofibromatosis Type I: From Genetic Mutation to Tumor Formation
Thomas, S. L., & Vries, G. H. D. (2008) · Springer eBooks · doi:10.1007/978-0-387-30375-8_6 · Cited by 3
Miller, C. R., Karpinich, N. O., Zhang, Q., Bullitt, E., Kozlov, S., & Dyke, T. V. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-553-8_7 · Cited by 3
Heritable predispositions to childhood hematologic malignancies
Le, D., Shannon, K., & Lange, B. J. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511471001.014 · Cited by 3
Patogênese molecular do feocromocitoma
Dahia, P. L. M. (2001) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302001000600003 · Cited by 3
Genetics and Pathway in Neurofibromatosis Type 1
Denayer, E., Legius, E., & Brems, H. (2020) · Springer eBooks · doi:10.1007/978-3-319-92450-2_2 · Cited by 3
Barton, P. J. R., Boheler, K. R., Brand, N. J., & Thomas, P. S. (1995) · Medical intelligence unit · doi:10.1007/978-3-662-22192-1_2 · Cited by 3
Bibliometric analysis of the top 100 most-cited articles in neurofibromatosis
Alnefaie, N. T., Almutairi, O. T., Alturki, A. Y., & Bafaquh, M. S. (2022) · Surgical Neurology International · doi:10.25259/sni_114_2022 · Cited by 3
Molecular Basis of Cardiovascular Abnormalities in NF1
Stansfield, B. K., Ingram, D. A., Conway, S. J., & Friedman, J. M. (2012) · Springer eBooks · doi:10.1007/978-3-642-32864-0_23 · Cited by 3
The Central Nervous System in Neurofibromatosis Type 1
Ratner, N., & North, K. N. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-353-8_5 · Cited by 3
Self-citationPeltonen, J. T. K., & Peltonen, S. A. (2008) · KARGER eBooks · doi:10.1159/000126565 · Cited by 3
Multiple Myofibromas and an Epidermal Verrucous Nevus in a Child with Neurofibromatosis Type 1
Schepper, S. D., Janssens, S., Messiaen, L. M., den Broecke, C. V., & Naeyaert, J. (2004) · Dermatology · doi:10.1159/000079894 · Cited by 3
Glioma Oncogenesis and Animal Models of Glioma Formation
Lyustikman, Y., & Lassman, A. B. (2006) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2006.09.005 · Cited by 3
Kim, H. A., & Ratner, N. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5949-8_20 · Cited by 3
Self-citationGenes del desarrollo y enfermedad cardíaca
Ruiz‐Lozano, P., Nakamura, T., & Chien, K. R. (2001) · Revista Española de Cardiología · doi:10.1016/s0300-8932(01)76527-x · Cited by 3
Gene targeting approaches to the autonomic nervous system
Fritz, J. D., & Robertson, D. (1996) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(96)00055-0 · Cited by 3
Establishment of embryonic stem cell lines
Ledermann, B. (1996) · Elsevier eBooks · doi:10.1016/b978-012442710-5.50022-8 · Cited by 3
An Osteoblast Origin for Craniofacial Dysplasia in Neurofibromatosis Type I
Bamaga, I. K. (2017) · Journal of Dental Health Oral Disorders and Therapy · doi:10.15406/jdhodt.2017.06.00223 · Cited by 2
del Monte‐Nieto, G., & Harvey, R. P. (2021) · Springer eBooks · doi:10.1007/978-3-030-54779-0_2 · Cited by 2
History of the study of the neural crest (review)
Pakhomova, N. Y., Strokova, E. L., Korytkin, A. A., Kozhevnikov, V. V., Gusev, A. F., & Zaydman, A. M. (2023) · Сибирский научный медицинский журнал · doi:10.18699/ssmj20230102 · Cited by 2
NF1 Mutations in Hematologic Cancers
Chang, T. Y., & Shannon, K. (2012) · Springer eBooks · doi:10.1007/978-3-642-32864-0_30 · Cited by 2
The Molecular Biology of Neurofibromatosis Type 1
Upadhyaya, M. (2014) · Colloquium Series on Genomic and Molecular Medicine · doi:10.4199/c00101ed1v01y201312gmm005 · Cited by 2
von Recklinghausen Disease: 130 Years
Riccardi, V. M. (2012) · Springer eBooks · doi:10.1007/978-3-642-32864-0_1 · Cited by 2
RASopathies et cancers de l’enfant
Strullu, M., Caye‐Eude, A., Verloès, A., & Cavé, H. (2015) · Revue d Oncologie Hématologie Pédiatrique · doi:10.1016/j.oncohp.2015.07.004 · Cited by 2
Krone, W., & Kehrer‐Sawatzki, H. (2001) · Springer eBooks · doi:10.1007/978-3-642-56889-3_6 · Cited by 2
Dong, M.-J., Yang, Z., Yang, J., Guo, R.-Q., Xiao, Y.-Y., & Liu, H. (2022) · Medicine · doi:10.1097/md.0000000000029280 · Cited by 2
Molecular Basis of Bone Abnormalities in NF1
Stevenson, D. A., & Elefteriou, F. (2012) · Springer eBooks · doi:10.1007/978-3-642-32864-0_21 · Cited by 2
Miocardiopatía hipertrófica obstructiva y neurofibromatosis de tipo 1
Calvo, A. S., Sanz, A. S., Martí‐Bonmatí, L., Ferreres, F. A., & Vaquerizo, B. (2004) · Anales de Pediatría · doi:10.1016/s1695-4033(04)78227-2 · Cited by 2
Transgenic models and cancer treatment
Coletta, P. L., Cartwright, E. J., & Markham, A. F. (1995) · Cancer Treatment Reviews · doi:10.1016/0305-7372(95)90019-5 · Cited by 2
Genetic Mechanisms of Memory Disorders (Excluding Alzheimer's Disease)
Kaas, G. A., Hawkins, K. E., & Sweatt, J. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.21125-5 · Cited by 3
Moreno‐Rodriguez, R. A., & Krug, E. L. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00702-8 · Cited by 2
Molecular biological approaches to genetic cardiac diseases
McQuinn, T. (1996) · Progress in Pediatric Cardiology · doi:10.1016/1058-9813(96)00167-1 · Cited by 2
Model systems for neurofibroma and malignant peripheral nerve sheath tumor
Ratner, N., & Miller, S. J. (2006) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2006.06.001 · Cited by 2
Self-citationAn update on mouse brain tumor models in cancer drug discovery
Hambardzumyan, D., Lyustikman, Y., & Holland, E. C. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.11.1435 · Cited by 2
Neurofibromin is essential to maintain metabolic function and sustain life in the adult mousePreprint
Turner, A. N., Johnson, M. S., Brosius, S. N., Yoder, B. S., Yang, K., Yang, Q., Moore, J. F., Yang, Q., Moore, J. F., Sharer, J. D., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/324061 · Cited by 2
Kogan, S. C. (2004) · Wiley eBooks · doi:10.1002/0471675067.mmc013 · Cited by 2
Bettinaglio, P., Tritto, V., Paterra, R., Eoli, M., & Riva, P. (2023) · Annals of Human Genetics · doi:10.1111/ahg.12540 · Cited by 1
Zebrafish neurofibromatosis type 1 mutants show disruption of sleep but not of circadian rhythms
Lee, D. A., Oikonomou, G., Chiu, Y., Cho, A. D., Xu, J., Cammidge, T., Singh, C., & Prober, D. A. (2025) · SLEEP · doi:10.1093/sleep/zsaf236 · Cited by 1
Neurofibromatosis Type 1: Future Directions (Where Do We Go from Here?)
Parada, L. F. (2012) · Springer eBooks · doi:10.1007/978-3-642-32864-0_44 · Cited by 1
Self-citationAssessment of Tumor Prevention in Type 1 Neurofibromatosis using a Nitroxide Compound
El‐Hoss, J., Micallef, A. S., Fairfull‐Smith, K. E., Bottle, S. E., Little, D. G., & Schindeler, A. (2011) · Free Radicals and Antioxidants · doi:10.5530/ax.2011.3.3 · Cited by 1
Hussain, I., & Gutmann, D. (2011) · Expert Review of Ophthalmology · doi:10.1586/eop.11.31 · Cited by 1
Mosaicismo clínico y genético en la neurofibromatosis tipo 1
Gilaberte, M., Lázaro, C., & Pujol, R. M. (2006) · Piel · doi:10.1016/s0213-9251(06)72545-x · Cited by 1
Signaling Pathways in Cardiovascular Development
Marı́n-Garcı́a, J. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9461-5_9 · Cited by 1
Huson, S., & Korf, B. R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00128-2 · Cited by 1
The Heart in Neurofibromatosis 1
Bergqvist, C., & Wolkenstein, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-54779-0_7 · Cited by 1
Ekure, E. N., Musa, K. O., Ulonnam, N., Kruszka, P. S., Muenke, M., & Adeyemo, A. (2023) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63317 · Cited by 1
The History of the Study of the Neural Crest (Overview)
Pakhomova, N. Y., Strokova, E. L., Korytkin, A. A., Kozhevnikov, V. V., Gusev, A. F., & Zaidman, A. M. (2023) · Cell and Tissue Biology · doi:10.1134/s1990519x23050097 · Cited by 1
Darle, A., Mahiet, T., Aubin, D., Doyen, M., Kassar, L. E., Parfait, B., Lemaı̂tre, G., Baldeschi, C., Allouche, J., & Holic, N. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1359561 · Cited by 1
Progression and perspectives in disease modeling for Juvenile myelomonocytic leukemia
Fu, S., Guo, Y., Peng, Z., Zhang, D., Chang, Z., Xiao, Y., Zhang, Q., Yu, L., Chen, C., Chen, Y., et al. (2024) · Medical Oncology · doi:10.1007/s12032-024-02549-5 · Cited by 1
Padmanabhan, A., & Epstein, J. A. (2012) · Springer eBooks · doi:10.1007/978-3-642-32864-0_35 · Cited by 1
Cardiac Development: Toward a Molecular Basis for Congenital Heart Disease
Schneider, M. D., & Olson, E. N. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_52 · Cited by 1
Insights into synaptic function from mouse models of human cognitive disorders
Banko, J. L., Trotter, J. H., & Weeber, E. J. (2010) · Future Neurology · doi:10.2217/fnl.10.80 · Cited by 1
Costa, R. M., Elgersma, Y., & Silva, A. J. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-353-8_3 · Cited by 3
Regulation of somatosensory cortex development downstream of glutamate
Petrie, A. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Neurofibromatosis Type I ( NF 1)
Viskochil, D. H. (2009) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0005534.pub2 · Cited by 1
Microdeletions and molecular genetics
Vogels, A., & Fryns, J. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/38088 · Cited by 1
From genes to therapies: the role of animal models
Silva, A. J., Elgersma, Y., & Costa, R. M. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(01)00005-6 · Cited by 1
Koivunen, J. P. (2003) · Cited by 1
Epidemiological, clinical and genetic aspects of neurofibromatoses in Northern Finland
Pöyhönen, M. (1999) · Cited by 1
Wei, X., Lienhard, M., Murgai, A., Franke, J., Pöhle‐Kronawitter, S., Kotsaris, G., Wu, H., Boerno, S. T., Timmermann, B., Glauben, R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.28.462168 · Cited by 1
Novel Systems for the Study of Human Disease
OECD (1998) · OECD eBooks · doi:10.1787/9789264162389-en · Cited by 1
Bernards, A., & McClatchey, A. I. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-230-2_11 · Cited by 1
Shared Alteration of Whole-Brain Connectivity and Olfactory Deficits in Multiple Autism Mouse ModelsPreprint
Hsu, T., Chen, C.-P., Lin, M.-H., Huang, T., Wang, C.-Y., Lee, C.-M., Chen, B., Wang, C.-Y., & Hsueh, Y. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.02.636175 · Cited by 1
Neurofibromatosis (NF) types 1 and 2
Huson, S. (1996) · Springer eBooks · doi:10.1007/978-1-4899-4501-3_5
Animal Models of Hematopoietic Growth Factor Perturbations in Physiology and Pathology
Lieschke, G. J. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-747-5_2
Advances in NF1 Animal Models and Lessons Learned
Maertens, O., & Cichowski, K. M. (2012) · Springer eBooks · doi:10.1007/978-3-642-32864-0_33
Rigou, P., Faye, A., & Poyet, J. (2009) · Springer eBooks · doi:10.1007/978-90-481-3415-1_12
Mitu, O., Tesloianu, D. N., Tudorancea, I., Dănilă, N., & Petriş, A. O. (2014) · Archive of Clinical Cases · doi:10.22551/2014.04.0103.10022
Ras Signaling Pathway in Biology and Therapy of Malignant Peripheral Nerve Sheath Tumors
Farassati, F. (2012) · Springer eBooks · doi:10.1007/978-3-642-32864-0_38
The Role of p120 RasGAP in T Cells and Lymphatics.
Lapinski, P. E. (2009) · Deep Blue (University of Michigan)
Preclinical Mouse Models of Neurofibromatosis
Shannon, K., McClatchey, A. I., Parada, L. F., Giovanni, M. D., & Jack, T. (2001) · Defense Technical Information Center (DTIC) · doi:10.21236/ada404608
Self-citationTowbin, J. A., & Belmont, J. W. (2002) · Springer eBooks · doi:10.1007/978-3-642-56225-9_3
Bone Health, Osteoporosis and Fracture Risk in Neurofibromatosis 1 - An Emphasis on Osteoclasts
Heervä, E. (2012) · UTUPub (University of Turku)
Neurofibromin and IL-4 as Regulators of T Cell Development, Function, and Homeostasis
Oliver, J. A. (2012) · Deep Blue (University of Michigan)
Garcia, C. M., & Gutmann, D. H. (2014) · Scientifica · doi:10.1155/2014/915725
Williams, J. P., Wu, J., Johansson, G., Mukouyama, Y., Cancelas, J. A., & Ratner, N. (2008) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2008.09.056
Self-citationPre-clinical transgenic mouse models of nervous system tumors
Agnihotri, S., Muñoz, D. M., & Guha, A. (2010) · Translational Neuroscience · doi:10.2478/v10134-010-0018-7
Αναστολή της PKC-ε και μηχανισμοί ογκογένεσης στο ΚΝΣ
Κολιού, Ξ. (2012) · doi:10.12681/eadd/27973
Dissecting Neurofibromatosis Type 1 Related Vasculopathy
Lasater, E. A. (2010) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1788
Vogel, K. S. (2002) · doi:10.21236/ada411714
Self-citationPeripheral Nervous System Tumors
Gutmann, D. H., Perry, A., Rangwala, R. A., & Sherman, L. S. (2004) · doi:10.1002/0471675067.mmc011
the t(8;21) Fusion Protein Neurofibromatosis-1 Tumor Suppressor by Transcriptional Repression of the
Hiebert, S. W., Gutmann, D. H., Delwel, R., Clapp, D. W., Gao, M., Khalaf, W. F., & van de Locht, L. T. (2014)
RAPID REPORT Biochemical and Functional Characterization of Germ Line KRAS Mutations
Schubbert, S., Bollag, G. E., Lyubynska, N., Nguyen, H. T., Kratz, C. P., Zenker, M., Niemeyer, C. M., Molven, A., & Shannon, K. (2007)
Donahoe, J. S., Parada, L. F., Gutmann, D. H., Bajenaru, M. L., & Hedrick, N. M. (2014)
Self-citationMolecular and Cellular Mechanisms of Learning Disabilities: A Focus on Neurofibromatosis Type I
Shilyansky, C., Li, W., Acosta, M. T., Elgersma, Y., Hannan, F., Hardt, M. E., Hunter-Schaedle, K., Krab, L. C., Legius, E., Wiltgen, B. J., et al. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00015-1
The role and function of the Ras-related protein TC21 in Neurofibromatosis type 1
Patmore, D. M. (2012) · OhioLink ETD Center (Ohio Library and Information Network)
Journal, A., Uhrhammer, N. A., Bay, J., & Gatti, R. A. (1999)
Zhang, J., Chang, J.-J., Xu, F., Ma, X., Wu, Y., Li, W.-C., Wang, H., Huang, G., & Ma, D. (2013)
Elsherif, M. A., Spinner, R. J., Tubbs, R. S., Persaud, T. V. N., & Fogelson, J. L. (2016) · Clinical Anatomy · doi:10.1002/ca.22715
Role of Nf1 signaling in regulating pigmentation in the mouse
Deo, M. (2012) · cIRcle (University of British Columbia) · doi:10.14288/1.0072689
New insights in the molecular pathogenesis of neurofibromatosis type 1
Maertens, O., & Messiaen, L. M. (2006) · Ghent University Academic Bibliography (Ghent University)
Kaul, A., Hussain, I., & Gutmann, D. H. (2012) · Neuromethods · doi:10.1007/7657_2011_29
Congenital and Acquired Heart Disease
Marı́n-Garcı́a, J. (2007) · Elsevier eBooks · doi:10.1016/b978-012373698-7/50007-3
Metadata
- Authors
- Brannan, C. I., Perkins, A. S., Vogel, K. S., Ratner, N., Nordlund, M. L., Reid, S. W., Buchberg, A. M., Jenkins, N. A., Parada, L. F., & Copeland, N. G.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1994-05-01
- Volume
- 8
- Issue
- 9
- Pages
- 1019-1029
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2159562139
- Cited by
- 641
- References
- 42
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 17 · 2023: 10 · 2022: 10 · 2021: 19 · 2020: 14 · 2019: 9 · 2018: 16 · 2017: 11 · 2016: 17 · 2015: 14 · 2014: 17 · 2013: 23 · 2012: 33
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Health and Human Services
- James S. McDonnell Foundation
- National Institutes of Health (n01co074101-034)
- National Cancer Institute (N01 CO-74101)
- National Institute of Neurological Disorders and Stroke (NS-28840, R01NS028840)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Health Sciences › Medicine › Oncology › Neuroblastoma Research and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- neurofibromatosis type 1, NF1 gene, neurofibromin, null mutations, cardiac anomalies, neural crest, Ras signaling, developmental abnormalities, mouse model
- MeSH terms
- Alleles, Animals, Base Sequence, Female, Embryonic and Fetal Development, Fetal Heart, Ganglia, Sympathetic, Heart Defects, Congenital, Homozygote, Kidney, Liver, Male, Mice, Inbred C57BL, Mice, Transgenic, Mitotic Index, Molecular Sequence Data, Mutation, Neural Crest, Genes, Neurofibromatosis 1, Gene Targeting, Muscle, Skeletal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review